Tuesday, April 20, 2010

EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device

LYON, France, Apr 12, 2010 (GlobeNewswire via COMTEX) -- EDAP TMS SA /quotes/comstock/15*!edap/quotes/nls/edap (EDAP 3.15, +0.00, +0.03%) , the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.

Leveraging EDAP's patented electroconductive technology, Sonolith i-move is a compact, stand alone lithotripter with a revolutionary infrared stereo-vision system for real-time, three-dimensional ultrasound localization of urinary stones. With its various modular configurations, Sonolith i-move targets the largest lithotripsy market segment, offering a wide range of treatment procedures for mid-size clinical sites and hospitals. Sonolith i-move will replace Sonolith Praktis, an earlier generation lithotripter, and complements the Company's high-end Sonolith I-sys lithotripter, an integration of x-ray and ultrasound locatization systems.

In addition to the official launch in Europe, EDAP is actively working towards filing for regulatory approval of Sonolith i-move in the U.S. and in Japan.

source: MarketWatch

No comments: